Marketing-authorisation holder Β· Canada
Eugia Pharma Inc.
90 medicines in 1 country, as authorisation holder.
Loading your pageβ¦
Marketing-authorisation holder Β· Canada
90 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1β25 of 90
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACETYLCYSTEINE INJECTION200 mg / ml Β· Solution | Acetylcysteine | Canada | Authorised | |
| ACYCLOVIR SODIUM INJECTION50 mg / ml Β· Solution | Aciclovir | Canada | Marketed | 2024 |
| AMPICILLIN SODIUM FOR INJECTION BP500 mg / vial Β· Powder For Solution | Ampicillin | Canada | Marketed | 2024 |
| AMPICILLIN SODIUM FOR INJECTION BP250 mg / vial Β· Powder For Solution | Ampicillin | Canada | Authorised | |
| AMPICILLIN SODIUM FOR INJECTION BP1 g / vial Β· Powder For Solution | Ampicillin | Canada | Marketed | 2024 |
| AMPICILLIN SODIUM FOR INJECTION BP2 g / vial Β· Powder For Solution | Ampicillin | Canada | Marketed | 2024 |
| ARSENIC TRIOXIDE FOR INJECTION2 mg / ml Β· Solution | Arsenicum album | Canada | Authorised | |
| AZITHROMYCIN FOR INJECTION, USP500 mg / vial Β· Powder For Solution | Azithromycin | Canada | Marketed | 2024 |
| BACITRACIN FOR INJECTION, USP50000 unit / vial Β· Powder For Solution | Bacitracin | Canada | Authorised | |
| BENDAMUSTINE HYDROCHLORIDE FOR INJECTION25 mg / vial Β· Powder For Solution | Bendamustine | Canada | Marketed | 2025 |
| BENDAMUSTINE HYDROCHLORIDE FOR INJECTION100 mg / vial Β· Powder For Solution | Bendamustine | Canada | Marketed | 2024 |
| BORTEZOMIB FOR INJECTION3.5 mg / vial Β· Powder For Solution | Bortezomib | Canada | Authorised | |
| BUPIVACAINE HEAVY INJECTION BP15 mg / 2 ml Β· Solution | Bupivacaine | Canada | Authorised | |
| BUPIVACAINE INJECTION BP2.5 mg / ml Β· Solution | Bupivacaine | Canada | Authorised | |
| BUPIVACAINE INJECTION BP5 mg / ml Β· Solution | Bupivacaine | Canada | Authorised | |
| BUSULFAN FOR INJECTION60 mg / 10 ml Β· Solution | Busulfan | Canada | Authorised | |
| CARBOPLATIN INJECTION10 mg / ml Β· Solution | Carboplatin | Canada | Authorised | |
| CYANOCOBALAMIN INJECTION USP1000 mcg / ml Β· Solution | Vitamin b12 | Canada | Authorised | |
| DAPTOMYCIN FOR INJECTION RF500 mg / vial Β· Powder For Solution | Daptomycin | Canada | Marketed | 2026 |
| DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION100 mcg / ml Β· Solution | Dexmedetomidine | Canada | Marketed | 2024 |
| DILTIAZEM HYDROCHLORIDE INJECTION5 mg / ml Β· Solution | Diltiazem | Canada | Authorised | |
| EPHEDRINE SULFATE INJECTION USP50 mg / ml Β· Solution | Ephedrine | Canada | Authorised | |
| ERTAPENEM FOR INJECTION1 g / vial Β· Powder For Solution | Ertapenem | Canada | Marketed | 2024 |
| EUGIA-ABIRATERONE500 mg Β· Tablet | Abiraterone | Canada | Authorised | |
| EUGIA-ABIRATERONE250 mg Β· Tablet | Abiraterone | Canada | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 90 | 90 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.